Cho Heeyeon
Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Korean J Pediatr. 2015 Jul;58(7):239-44. doi: 10.3345/kjp.2015.58.7.239. Epub 2015 Jul 22.
The complement system is part of the innate immune response and as such defends against invading pathogens, removes immune complexes and damaged self-cells, aids organ regeneration, confers neuroprotection, and engages with the adaptive immune response via T and B cells. Complement activation can either benefit or harm the host organism; thus, the complement system must maintain a balance between activation on foreign or modified self surfaces and inhibition on intact host cells. Complement regulators are essential for maintaining this balance and are classified as soluble regulators, such as factor H, and membrane-bound regulators. Defective complement regulators can damage the host cell and result in the accumulation of immunological debris. Moreover, defective regulators are associated with several autoimmune diseases such as atypical hemolytic uremic syndrome, dense deposit disease, age-related macular degeneration, and systemic lupus erythematosus. Therefore, understanding the molecular mechanisms by which the complement system is regulated is important for the development of novel therapies for complement-associated diseases.
补体系统是固有免疫反应的一部分,因此可抵御入侵病原体、清除免疫复合物和受损的自身细胞、促进器官再生、提供神经保护,并通过T细胞和B细胞参与适应性免疫反应。补体激活对宿主生物体可能有益也可能有害;因此,补体系统必须在外源或修饰的自身表面激活与完整宿主细胞抑制之间保持平衡。补体调节蛋白对于维持这种平衡至关重要,可分为可溶性调节蛋白,如H因子,以及膜结合调节蛋白。有缺陷的补体调节蛋白会损害宿主细胞并导致免疫碎片的积累。此外,有缺陷的调节蛋白与几种自身免疫性疾病有关,如非典型溶血性尿毒症综合征、致密物沉积病、年龄相关性黄斑变性和系统性红斑狼疮。因此,了解补体系统的调节分子机制对于开发针对补体相关疾病的新疗法很重要。